Search

Your search keyword '"Garcia Pinilla, Jose Manuel"' showing total 87 results

Search Constraints

Start Over You searched for: Author "Garcia Pinilla, Jose Manuel" Remove constraint Author: "Garcia Pinilla, Jose Manuel"
87 results on '"Garcia Pinilla, Jose Manuel"'

Search Results

1. Rare Genetic Variants in Young Adults Requiring Pacemaker Implantation

2. Repetitive ambulatory levosimendan as a bridge to heart transplantation

3. Levosimendán ambulatorio repetitivo como puente al trasplante cardiaco

6. Prevalence and clinical profile of kidney disease in patients with chronic heart failure. Insights from the Spanish cardiorenal registry

7. Prevalencia y perfil clínico de la enfermedad renal en pacientes con insuficiencia cardiaca crónica. Datos del Registro cardiorrenal español

8. Short-Term Changes in Peak VO2 After Initiation of Dapagliflozin in Heart Failure Across Iron Status

11. Caracterización de la amiloidosis cardiaca hereditaria por transtirretina en España

14. Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction

16. Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations

17. La consulta telemática para el cardiólogo clínico en tiempos de la COVID-19: presente y futuro. Documento de consenso de la Sociedad Española de Cardiología

18. Pronóstico al año en pacientes con insuficiencia cardiaca en España. Registro ESC-EORP-HFA Heart Failure Long-Term

19. NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study

22. Clinical Findings and Prognosis of Danon Disease. An Analysis of the Spanish Multicenter Danon Registry

25. Short-Term Changes in Peak VO2 After Initiation of Dapagliflozin in Heart Failure Across Iron Status

26. Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy

27. Genetic Etiology for Alcohol-Induced Cardiac Toxicity

28. Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation

33. Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy

34. Abstract P592: Risk Factors for Heart Failure Subtypes in a Population With a High Burden of Diabetes- Evidence From the Strong Heart Study

36. Adherence to the ESC Heart Failure Treatment Guidelines in Spain: ESC Heart Failure Long-term Registry

38. Short-term Changes in Hemoglobin and Changes in Functional Status, Quality of Life and Natriuretic Peptides After Initiation of Dapagliflozin in Heart Failure With Reduced Ejection Fraction

40. Short-Term Changes in Peak VO2After Initiation of Dapagliflozin in Heart Failure Across Iron Status

41. Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator

44. Coronary Disease Extension Determines Mobilization of Endothelial Progenitor Cells and Cytokines After a First Myocardial Infarction With ST Elevation

45. Short‐term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA‐VO2): a randomized clinical trial.

47. Influence of high homocysteine and low folate plasmatic levels in medium-term prognosis after acute coronary syndromes

50. NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction

Catalog

Books, media, physical & digital resources